These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 24898696)
1. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer. Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413 [TBL] [Abstract][Full Text] [Related]
3. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122 [TBL] [Abstract][Full Text] [Related]
4. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501 [TBL] [Abstract][Full Text] [Related]
5. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Ren D; Minami Y; Nishita M Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409 [TBL] [Abstract][Full Text] [Related]
7. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Bitler BG; Nicodemus JP; Li H; Cai Q; Wu H; Hua X; Li T; Birrer MJ; Godwin AK; Cairns P; Zhang R Cancer Res; 2011 Oct; 71(19):6184-94. PubMed ID: 21816908 [TBL] [Abstract][Full Text] [Related]
8. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma. Burkhalter RJ; Westfall SD; Liu Y; Stack MS J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151 [TBL] [Abstract][Full Text] [Related]
10. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells. Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663 [TBL] [Abstract][Full Text] [Related]
11. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling. Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492 [TBL] [Abstract][Full Text] [Related]
12. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598 [TBL] [Abstract][Full Text] [Related]
13. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis. Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283 [TBL] [Abstract][Full Text] [Related]
14. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. Wang B; Tang Z; Gong H; Zhu L; Liu X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966 [TBL] [Abstract][Full Text] [Related]
15. Effect of WNT5A on epithelial-mesenchymal transition and its correlation with tumor invasion and metastasis in nasopharyngeal carcinoma. Zhu HH; Zhu XY; Zhou MH; Cheng GY; Lou WH Asian Pac J Trop Med; 2014 Jun; 7(6):488-91. PubMed ID: 25066400 [TBL] [Abstract][Full Text] [Related]
16. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer. Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227 [TBL] [Abstract][Full Text] [Related]
17. Wnt5a influences viability, migration, adhesion, colony formation, E- and N-cadherin expression of human ovarian cancer cell line SKOV-3. Jannesari-Ladani F; Hossein G; Monhasery N; Shahoei SH; Izadi Mood N Folia Biol (Praha); 2014; 60(2):57-67. PubMed ID: 24785108 [TBL] [Abstract][Full Text] [Related]
18. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition. Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650 [TBL] [Abstract][Full Text] [Related]
19. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer]. Yu L; Wu SW; Zhou L; Song WQ Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329 [TBL] [Abstract][Full Text] [Related]
20. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells. Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]